0001140361-13-011911.txt : 20130312 0001140361-13-011911.hdr.sgml : 20130312 20130312093128 ACCESSION NUMBER: 0001140361-13-011911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130228 FILED AS OF DATE: 20130312 DATE AS OF CHANGE: 20130312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lieber Jonathan I CENTRAL INDEX KEY: 0001350090 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 13682728 MAIL ADDRESS: STREET 1: REPLIGEN CORP. STREET 2: 41 SEYON SSTREET, BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc1.xml FORM 4 X0306 4 2013-02-28 0 0000730272 REPLIGEN CORP RGEN 0001350090 Lieber Jonathan I C/O REPLIGEN CORPORATION 41 SEYON ST, BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 CFO Common Stock 15000 D Stock Option (Right to Buy) 6.23 2013-02-28 4 A 0 40000 0 A 2014-02-28 2023-02-28 Common Stock 40000 150000 D 15,000 shares will vest on September 20, 2013. 10,000 Options will vest and become exercisable on each of the following dates: 2/28/2014, 2/28/2015, 2/28/2016 and 2/28/2017. /s/ William J. Kelly (Attorney in Fact) 2013-03-12